enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip

enGene Holdings Inc. (NASDAQ: ENGN) Listen to this Section


$5.75
-0.1500 ( -2.54% ) 10.9K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open


$5.75

Previous close


$5.90

Volume


10.9K

Market cap


$268.97M

Day range


$5.48 - $6.13

52 week range


$5.10 - $43.00

Insider Ownership Transactions

Total Amount Purchased: -1,524,695.00 | $ -8,766,996.25

Date Type Amount Purchased Purchaser
2024-07-25 Sale -110000.00 Pruthi Raj Som
2024-07-24 Sale -1250000.00 Cooper Ronald Harold Wilfred
2024-06-18 Sale -20000.00 BRUNK GERALD A
2024-06-18 Sale -20000.00 Zoth Lota S.
2024-06-18 Sale -20000.00 Glickman Richard M
2024-06-18 Sale -40000.00 Joustra Wouter
2024-06-18 Sale -40000.00 HASTINGS PAUL J
2024-06-18 Sale -20000.00 Bos Jasper
2024-05-29 Sale -120.00 Glickman Richard M
2024-04-22 Sale -4575.00 FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jul 25, 2024
3 Insider transactions 2 Jul 25, 2024
8-k 8K-related 18 Jul 24, 2024
4 Insider transactions 1 Jul 24, 2024
3 Insider transactions 2 Jul 24, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.